New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Ghaghanda, Ketan B ^a   Ravoori, Murall ^b   Sabapathy, Divya ^a,c   Bankson, James ^b   Kundra, Vikas ^b   Annapraganda, Ananth ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL MODE GADOLINIUM; GADOLINIUM; LIPOSOME; METAL NANOPARTICLE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DRUG CARRIER; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTRAST SENSITIVITY; CONTROLLED STUDY; COW; IMAGE ANALYSIS; IMAGE PROCESSING; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MAGNETIC RESONANCE ANGIOGRAPHY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; SIGNAL NOISE RATIO; SURFACE PROPERTY; ANIMAL; CHEMISTRY; INSTRUMENTATION; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE;

BOVINAE;

ANIMALS; CONTRAST MEDIA; DRUG CARRIERS; GADOLINIUM; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MOLECULAR IMAGING; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 70449585195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007628     Document Type: Article

References (27)

1. Zhang H, Maki JH, Prince MR (2007) 3D contrast-enhanced MR angiography. J Magn Reson Imaging 25: 13-25.
2. Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17: 509-20.
3. Rosen MA, Schnall MD (2007) Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 13: 770s-776s.
4. Bremerich J, Bilecen D, Reimer P (2007) MR angiography with blood pool contrast agents. Eur Radiol 17: 3017-24.
5. Hadizadeh DR, Gieseke J, Lohmaier SH, Wilhelm K, Boschewitz J, et al. (2008) Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 249: 701-11.
6. Knopp MV, Giesel FL, von Tengg-Kobligk H, Radeleff J, Requardt M, et al. (2003) Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentate dimeglumine. J Magn Reson Imaging 17: 694-702.
7. Anzalone N, Scotti R, Vezzulli P (2006) High relaxivity contrast agents in MR angiography of the carotid arteries. Eur Radiol 16 Suppl 7: M27-34.
8. Ghaghada KB, Bockhorst KH, Mukundan S Jr, Annapragada AV, Narayana PA (2007) High-resolution vascular imaging of the rat spine using liposomal blood pool MR agent. AJNR 28: 48-53.
9. Tran TD, Caruthers SD, Hughes M, Marsh JN, Cyrus T, et al. (2007) Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomedicine 2: 515-26.
10. Frias JC, Williams KJ, Fisher EA, Fayad ZA (2004) Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 22: 16316-7.
11. Kobayashi H, Brechbiel MW (2005) Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57: 2271-86.
12. Tilcock C, Unger E, Cullis P, MacDougall P (1989) Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 171: 77-80.
13. Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan S Jr (2008) T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents - effect of liposome size and internal gadolinium concentration. Acad Radiol 15: 1259-63.
14. Mulder WJ, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, et al. (2004) A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 15: 799-806.
15. Ishida O, Maruyama K, Sasaki K, Iwatsuru M (1999) Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 190: 49-56.
16. Gabizon A, Shmeeda H, Barenholz Y (2003) Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 42: 419-36.
17. Ayyagari AL, Zhang X, Ghaghada KB, Annapragada A, Hu X, et al. (2006) Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Reson Med 55: 1023-9.
18. Bucholz E, Ghaghada K, Qi Y, Mukundan S, Johnson GA (2008) Four-dimensional MR microscopy of the mouse heart using radial acquisition and liposomal gadolinium contrast agent. Magn Reson Med 60: 111-8.
19. Karathanasis E, Chan L, Karumbaiah L, McNeeley K, D'Orsi CJ, et al. (2009) Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers. PLoS One 4: e5843.
20. Winter PM, Caruthers SD, Yu X, Song SK, Chen J, et al. (2003) Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 50: 411-6.
21. Port M, Corot C, Violas X, Robert P, Raynal I, et al. (2005) How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol 40: 565-73.
22. Storrs RW, Tropper FD, Li HY, Song CK, Sipkins DA, et al. (1995) Paramagnetic polymerized liposomes as new recirculating MR contrast agents. J Magn Reson Imaging 5: 719-24.
23. Szebeni J (2005) Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 216: 106-21.
24. Doxil® package insert - (www.fda.gov/Cder/foi/label/1999/ 50718s06lbl.pdf).
25. Ghaghada KB, Saul J, Natarajan JV, Bellamkonda RV, Annapragada AV (2005) Folate targeting of drug carriers: a mathematical model. J Control Release 104: 113-28.
26. Saul JM, Annapragada A, Natarajan JV, Bellamkonda RV (2003) Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release 92: 49-67.
27. McNeeley KM, Karathanasis E, Annapragada AV, Bellamkonda RV (2009) Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterial 30: 3986-3995.